Quality of Life in Polycystic Ovary Syndrome After Anti-Androgen Therapy Using PCOSQOL-47 and PCOSQOL-42

    Samih Abed Odhaib, Mahmood Thamer Altemimi, Adel Gassab Mohammed … Abbas Ali Mansour
    Studysummary This study found that in women with PCOS, a combination of finasteride and spironolactone significantly improved all health-related quality of life scales and reduced hyperandrogenism within four months, supporting its role alongside lifestyle measures.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on eurekaselect.com →
    Discuss this study in the Community →